Table 4 Altered metabolites between participants with cholangiocarcinoma from United Kingdom (n = 10) and Thailand (n = 14).

From: Mapping of population disparities in the cholangiocarcinoma urinary metabolome

m/z

RT

Tentative assignment

Adduct

VIP

p value

FC

Identification

162.113

0.50

L-carnitine (C1)

M + H

4.5

NS

2.14

a

114.065

0.52

Creatinine

M + H

6.5

NS

 − 1.18

b

144.102

0.58

Proline betaine

M + H

4.6

NS

1.22

b

229.119

0.59

Hydroxyprolyl-Proline

M + H

5.6

NS

1.17

b

160.133

0.70

Unknown

 

5.0

NS

3.41

d

204.125

0.83

L-Acetylcarnitine (C2)

M + H

10.8

NS

1.13

a

166.073

1.17

7-Methylguanine

M + H

4.5

NS

 − 1.35

b

150.078

1.21

N-methyladenine

M + H

4.7

0.014

 − 1.88

 

153.066

2.20

N-methyl-2-pyridone-5-carboxamide

M + H

5.2

NS

 − 1.31

b

265.117

3.93

Unknown

 

4.9

0.002

2.81

d

279.132

4.44

Dipeptide C14H18N2O4

M + H

4.8

0.004

7.76

c

287.207

4.93

Acylcarnitine (C8:1)

M + H

6.0

 < 0.001

4.1

b

310.202

5.35

Acylcarnitine (C10:3)

M + H

8.0

0.01

3.73

b

314.233

5.78

Decenoylcarnitine (C10:1)

M + H

4.7

NS

1.01

b

135.030

0.50

Threonate/Erythronate

M-H

3.3

NS

 − 1.34

b

191.018

0.65

Isocitrate

M-H

4.6

NS

1.37

a

243.061

0.85

Uridine/pseudouridine

M-H

3.7

NS

1.44

b

191.018

1.07

Citrate

M-H

5.3

NS

 − 1.44

a

260.022

1.79

Unknown

M-H

3.2

NS

 − 1.13

d

216.032

1.92

Tyramine-O-sulfate

M-H

3.3

NS

3.48

b

277.003

3.64

Unknown

M-H

4.1

0.050

6.12

b

263.102

3.84

Phenylacetylglutamine

M-H

6.5

NS

−1.04

b

243.134

4.18

Hydroxyprolyl-Isoleucine

M-H

4.3

0.041

2.29

b

269.149

4.91

Unknown

 

5.6

 < 0.001

2.76

c

329.16

5.63

Unidentified steroid

M-H

3.3

NS

9.74

c

331.175

5.99

Unidentified steroid

M-H

3.4

NS

1.10

c

514.283

6.09

Taurocholic acid

M-H

4.4

NS

2.43

b

464.301

6.24

Glycocholic acid

M-H

3.2

NS

−2.32

a

  1. FC = fold change; RT = retention time; VIP = variable importance in projection score Level of metabolite identification: (a) identified compound; (b) putatively annotated compound; (c) putatively characterised compound class; and (d) unknown False discovery rate adjusted p-value (or q-value).